Abortifacient Agents, Nonsteroidal
"Abortifacient Agents, Nonsteroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Non-steroidal chemical compounds with abortifacient activity.
MeSH Number(s)
D27.505.696.875.131.100
D27.505.954.705.131.100
Concept/Terms
Abortifacient Agents, Nonsteroidal- Abortifacient Agents, Nonsteroidal
- Agents, Nonsteroidal Abortifacient
- Nonsteroidal Abortifacient Agents
- Abortifacient Agents, Non-Steroidal
- Abortifacient Agents, Non Steroidal
- Agents, Non-Steroidal Abortifacient
- Non-Steroidal Abortifacient Agents
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents, Nonsteroidal".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents, Nonsteroidal".
This graph shows the total number of publications written about "Abortifacient Agents, Nonsteroidal" by people in Harvard Catalyst Profiles by year, and whether "Abortifacient Agents, Nonsteroidal" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 1 | 2 | 3 |
| 2010 | 0 | 1 | 1 |
| 2012 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 2 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Abortifacient Agents, Nonsteroidal" by people in Profiles.
-
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception. 2023 04; 120:109955.
-
Acute complications with same-day versus overnight cervical preparation before dilation and evacuation at 14 to 16 weeks. Contraception. 2023 01; 117:61-66.
-
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location. Obstet Gynecol. 2022 05 01; 139(5):771-780.
-
Stocking and over-the-counter sale of misoprostol for medical abortion in Ghana's community pharmacies: comparison of questionnaire and mystery client survey. Int J Pharm Pract. 2020 Jun; 28(3):267-274.
-
Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center. Obstet Gynecol. 2018 11; 132(5):1285-1295.
-
Letrozole pretreatment prior to medical termination of pregnancy: a systematic review. Contraception. 2018 06; 97(6):504-509.
-
New Evidence to Guide Ectopic Pregnancy Diagnosis and Management. Obstet Gynecol Surv. 2017 Oct; 72(10):618-625.
-
Outcomes of nonsurgical versus surgical treatment of cesarean scar pregnancies in the first trimester. Arch Gynecol Obstet. 2017 09; 296(3):533-541.
-
Outpatient endometrial aspiration: an alternative to methotrexate for pregnancy of unknown location. Am J Obstet Gynecol. 2017 08; 217(2):185.e1-185.e9.
-
Subsequent pregnancy outcome of tubal ectopic pregnancies treated by methotrexate and salpingectomy. Eur J Obstet Gynecol Reprod Biol. 2017 May; 212:192-193.